Cell Cycle Regulation via p53 Phosphorylation by a 5′-AMP Activated Protein Kinase Activator, 5-Aminoimidazole- 4-Carboxamide-1-β- -Ribofuranoside, in a Human Hepatocellular Carcinoma Cell Line
- 1 September 2001
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 287 (2), 562-567
- https://doi.org/10.1006/bbrc.2001.5627
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare
This publication has 20 references indexed in Scilit:
- Effects of Stimulation of AMP-activated Protein Kinase on Insulin-like Growth Factor 1- and Epidermal Growth Factor-dependent Extracellular Signal-regulated Kinase PathwayPublished by Elsevier ,2001
- Suppression of Anti‐microtubule Agent‐induced Apoptosis by Nitric Oxide: Possible Mechanism of a New Drug ResistanceJapanese Journal of Cancer Research, 1998
- RB kinases and RB-binding proteins: new points of viewTrends in Biochemical Sciences, 1997
- Acadesine: A new drug that may improve myocardial protection in coronary artery bypass grafting: Results of the first international multicenter studyThe Journal of Thoracic and Cardiovascular Surgery, 1995
- The retinoblastoma protein and cell cycle controlCell, 1995
- Inducible Nitric Oxide Synthase in a Human Glioblastoma Cell LineJournal of Neurochemistry, 1995
- Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cell‐permeable activator of AMP‐activated protein kinaseFEBS Letters, 1994
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Tissue distribution of the AMP‐activated protein kinase, and lack of activation by cyclic‐AMP‐dependent protein kinase, studied using a specific and sensitive peptide assayEuropean Journal of Biochemistry, 1989
- Aminoimidazole carboxamide ribonucleoside toxicity: A model for study of pyrimidine starvationJournal of Cellular Physiology, 1981